Literature DB >> 19011423

Unexpected low-level viremia among HIV-infected Ugandan adults with untreated active tuberculosis.

Padmini Srikantiah, Joseph K Wong, Teri Liegler, Maria Walusimbi, Harriet Mayanja-Kizza, Harriet K Kayanja, Roy D Mugerwa, Edwin D Charlebois, W Henry Boom, Christopher C Whalen, Diane V Havlir.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19011423      PMCID： PMC4752197          DOI： 10.1097/QAI.0b013e31817e9fb4

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  15 in total

Review 1.  Regression to the mean: what it is and how to deal with it.

Authors:  Adrian G Barnett; Jolieke C van der Pols; Annette J Dobson
Journal:  Int J Epidemiol       Date:  2004-08-27       Impact factor: 7.196

2.  Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis: a phase 2 clinical trial in Uganda.

Authors:  Harriet Mayanja-Kizza; Edward Jones-Lopez; Alphonse Okwera; Robert S Wallis; Jerrold J Ellner; Roy D Mugerwa; Christopher C Whalen
Journal:  J Infect Dis       Date:  2005-02-08       Impact factor: 5.226

3.  Effect of Plasmodium falciparum malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: a prospective cohort study.

Authors:  James G Kublin; Padmaja Patnaik; Charles S Jere; William C Miller; Irving F Hoffman; Nelson Chimbiya; Richard Pendame; Terrie E Taylor; Malcolm E Molyneux
Journal:  Lancet       Date:  2005 Jan 15-21       Impact factor: 79.321

4.  Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy.

Authors:  Gillian L Dean; Simon G Edwards; Natalie J Ives; Gail Matthews; Emma F Fox; Lesley Navaratne; Martin Fisher; Graham P Taylor; Rob Miller; Chris B Taylor; Annemiek de Ruiter; Anton L Pozniak
Journal:  AIDS       Date:  2002-01-04       Impact factor: 4.177

5.  Development of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 and performance of an improved AMPLICOR HIV-1 MONITOR test with isolates of diverse subtypes.

Authors:  N L Michael; S A Herman; S Kwok; K Dreyer; J Wang; C Christopherson; J P Spadoro; K K Young; V Polonis; F E McCutchan; J Carr; J R Mascola; L L Jagodzinski; M L Robb
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

6.  Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation.

Authors:  D Goletti; D Weissman; R W Jackson; N M Graham; D Vlahov; R S Klein; S S Munsiff; L Ortona; R Cauda; A S Fauci
Journal:  J Immunol       Date:  1996-08-01       Impact factor: 5.422

Review 7.  Attenuation of HIV-1 infection by other microbial agents.

Authors:  Saman Kannangara; Joseph A DeSimone; Roger J Pomerantz
Journal:  J Infect Dis       Date:  2005-08-12       Impact factor: 5.226

8.  Inhibition of HIV-1 replication in monocyte-derived macrophages by Mycobacterium tuberculosis.

Authors:  Delia Goletti; Stefania Carrara; Donatella Vincenti; Elena Giacomini; Lanfranco Fattorini; Anna Rosa Garbuglia; Maria Rosaria Capobianchi; Tonino Alonzi; Gian Maria Fimia; Maurizio Federico; Guido Poli; Eliana Coccia
Journal:  J Infect Dis       Date:  2004-02-04       Impact factor: 5.226

9.  Early virological response of zidovudine/lamivudine/abacavir for patients co-infected with HIV and tuberculosis in Uganda.

Authors:  Padmini Srikantiah; Maria N Walusimbi; H Kose Kayanja; Harriet Mayanja-Kizza; Roy D Mugerwa; Royce Lin; Edwin D Charlebois; W Henry Boom; Christopher C Whalen; Diane V Havlir
Journal:  AIDS       Date:  2007-09-12       Impact factor: 4.177

10.  Human immunodeficiency virus-1 RNA levels and CD4 lymphocyte counts, during treatment for active tuberculosis, in South African patients.

Authors:  Lynn Morris; Desmond J Martin; Helba Bredell; Stephina N Nyoka; Leonard Sacks; Stella Pendle; Liesl Page-Shipp; Christopher L Karp; Timothy R Sterling; Thomas C Quinn; Richard E Chaisson
Journal:  J Infect Dis       Date:  2003-06-04       Impact factor: 5.226
View more
  3 in total

1.  Current Views on the Pathophysiology of GB Virus C Coinfection with HIV-1 Infection.

Authors:  Esaki Muthu Shankar; Pachamuthu Balakrishnan; Ramachandran Vignesh; Vijayakumar Velu; Palanisamy Jayakumar; Suniti Solomon
Journal:  Curr Infect Dis Rep       Date:  2011-02       Impact factor: 3.725

2.  Tuberculosis treatment in HIV infected Ugandans with CD4 counts>350 cells/mm reduces immune activation with no effect on HIV load or CD4 count.

Authors:  C Scott Mahan; Maria Walusimbi; Denise F Johnson; Christina Lancioni; Edwin Charlebois; Joyce Baseke; Keith A Chervenak; Roy D Mugerwa; Diane V Havlir; Harriet Mayanja-Kizza; Christopher C Whalen; W Henry Boom
Journal:  PLoS One       Date:  2010-02-22       Impact factor: 3.240

Review 3.  Mollicutes/HIV Coinfection and the Development of AIDS: Still Far from a Definitive Response.

Authors:  Caio Mauricio Mendes de Cordova; Caroline Galgowski; Leonardo Lange
Journal:  Can J Infect Dis Med Microbiol       Date:  2016-06-16       Impact factor: 2.471
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.